Progenitor cell proliferation in the retina is dependent on Notch-independent Sonic hedgehog/Hes1 activity by Wall, Dana S. et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
JCB: ARTICLE
The Rockefeller University Press    $30.00
J. Cell Biol. Vol. 184 No. 1  101–112
www.jcb.org/cgi/doi/10.1083/jcb.200805155 JCB 101
  Correspondence to Valerie A. Wallace: vwallace@ohri.ca 
  Abbreviations used in this paper: ChIP, chromatin immunoprecipitation; CNS, 
central nervous system; CRALBP, cellular retinaldehyde-binding protein; DAPT, 
  N  -[  N  -(3,5-diﬂ  uorophenacetyl)-  L  -alanyl]-S-phenylglycine t-butyl ester; DIV, days in 
vitro; E, embryonic day; Hh, Hedgehog; IHC, immunohistochemistry; ISH, in situ 
hybridization; P, postnatal day; Ptch, Patched; RGC, retinal ganglion cell; RPC, 
retinal progenitor cell; RT-qPCR, quantitative RT-PCR; Shh, Sonic hedgehog; 
Smo, Smoothened.   
        Introduction 
  The neural retina represents an attractive model for investigat-
ing the molecular basis of progenitor cell proliferation and 
cell fate diversifi  cation in the central nervous system (CNS). 
The advantages of the retinal model system arise from the ca-
pacity for in vivo and in vitro analyses, the limited number of 
neurons and glial cell types comprising the mature retina, and 
the high degree of conservation of many developmental sig-
naling mechanisms (  Donovan and Dyer, 2005  ). The retinal 
cell types are derived in a temporal sequence from a common 
pool of multipotent progenitor cells (  Young, 1985  ;   Cepko et al., 
1996  ). This conserved birth order is dependent on both intrinsic 
changes in competence of progenitor cells as well as cellular 
responses to environmental cues (  Waid and McLoon, 1998  ; 
  Belliveau et al., 2000  ;   Zhang and Yang, 2001  ;   Cayouette et al., 
2003  ;   Kim et al., 2005  ). 
  The Sonic hedgehog (Shh) pathway is a highly conserved 
cell extrinsic regulator of progenitor cell proliferation and diver-
sifi  cation in many tissues, including the developing CNS and 
neural retina (  Marti and Bovolenta, 2002  ;   Dakubo and Wallace, 
2004  ). Patched (Ptch) is the transmembrane receptor for Shh 
and normally antagonizes the activity of the transmembrane 
protein Smoothened (Smo), which is required for the activation 
of the Gli zinc fi  nger transcription factors. Shh binding to Ptch 
alleviates the Ptch-mediated repression of Smo, allowing acti-
vation of Gli transcription factors and expression of target genes 
(  Villavicencio et al., 2000  ). 
  In the mouse retina, Shh is secreted from postmitotic 
retinal ganglion cells (RGCs) and targets retinal progenitor 
cells (RPCs;   Wang et al., 2005  ). Activation of the Shh path-
way increases the proliferation of RPCs (  Jensen and Wallace, 
1997  ;   Levine et al., 1997  ;   Black et al., 2003  ;   Moshiri and 
Reh, 2004  ;   Moshiri et al., 2005  ;   Wang et al., 2005  ), whereas 
conditional inactivation of   Shh   results in decreased numbers 
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  Results 
  Hes1 is activated by Shh signaling in a 
temporally regulated manner 
  To investigate the Shh dependence of   Hes   gene expression in 
RPCs, we used retina organ cultures (explants) derived from 
postnatal mice (  Fig. 1 a  ). Key features of normal retinal develop-
ment, including critical cell fate decisions, are recapitulated in 
retinal cell explant cultures (  Zhang et al., 2002  ). We have shown 
previously that Shh induction of target genes is abolished in post-
natal mouse retinal explants due to the death of Shh-secreting 
RGCs because of a lack of trophic support from target tissues in 
the CNS (  Wang et al., 2002  ). We treated retinal explants with a 
Smo agonist (  Frank-Kamenetsky et al., 2002  ), which restores 
Hedgehog (Hh) target gene expression (  Wang et al., 2005  ), and 
analyzed   Hes   induction by quantitative RT-PCR (RT-qPCR). 
Activation of the Shh pathway in retinal explants derived from 
postnatal mice results in an     20-fold induction of   Hes1   mRNA 
(  Fig. 1 b  ). Interestingly, Shh signaling in explants cultured from 
embryonic day 14 (E14) retinas resulted in only a twofold induc-
tion of   Hes1   mRNA, which indicates temporal regulation of the 
magnitude of   Hes1   expression by the Shh pathway. The modest 
induction of   Hes1   at E14 is not caused by a lack of progenitor 
cell competence to respond to Shh because the Hh target gene, 
  Gli1  , is potently activated by Shh in both E14 and postnatal reti-
nal explants (  Fig. 1 b  ). These data indicate that   Hes1   is inducible 
by Shh signaling at developmental stages when Shh is regulating 
both RGC development and RPC proliferation. A similar tempo-
ral regulatory pattern was observed for   Hes5   in response to Shh 
signaling. Shh activation resulted in a fi  vefold induction of   Hes5  
mRNA in postnatal retinal explants, whereas no signifi  cant in-
duction was observed in E14 explants (  Fig. 1 b  ). Shh pathway 
activation also results in stabilization of Hes1 protein (  Fig. 1 c  ), 
whereas Hes1 protein was undetectable in untreated explants de-
void of Shh ligand, which indicates that an active Hh pathway is 
necessary for the maintenance of Hes1 in RPCs. 
  Shh activation of Hes1 and Hes5 does not 
require the active NICD 
  Notch is a transmembrane protein and requires cleavage by a 
    -secretase complex to free its active intracellular domain (NICD) 
and induce target genes including   Hes1   and   Hes5   ( Kageyama  and 
Ohtsuka, 1999  ). To address whether Shh induction of   Hes1   and 
  Hes5   requires Notch signaling, we used a widely used chemical 
inhibitor of the     -secretase complex,   N -[ N -(3,5-difl  uorophen-
acetyl)-  l  -alanyl]-S-phenylglycine t-butyl ester (DAPT), to inhibit 
propagation of the Notch pathway (  Geling et al., 2002  ).   Hes5 , 
which is robustly expressed in untreated retinal explants, was used 
as a read-out for Notch signaling.   Hes5   was down-regulated in 
DAPT-treated retinal explants, which verifi  es Notch inactivation 
with DAPT treatment (  Fig. 2, m and o  ) and is consistent with pre-
vious reports showing the Notch dependence of   Hes5   expression 
in RPCs (  Nelson et al., 2007  ). Activation of the Hh pathway was 
accomplished using a constitutively active allele of Smo (Smo-M2; 
  Xie et al., 1998  ). Transfection of RPCs was accomplished 
using electroporation of transgenes in retinal explants. It has 
been previously found that transfection effi  ciency of postmitotic 
of progenitor cells, confi  rming a role for Shh in RPC prolif-
eration (  Wang et al., 2005  ). Genetic ablation of   Shh   in the 
embryonic mouse retina also results in increased RGC pro-
duction, revealing a role for Shh signaling in cell fate regu-
lation (  Wang et al., 2005  ). During later stages of retinal 
development, loss of Shh signaling results in a reduction of 
M  ü  ller glial cells and bipolar neurons, which is only restored 
with Shh pathway activation, indicating a potential instruc-
tive role for Shh in specifying cell fate (  Wang et al., 2002  ). 
Few Gli target genes important for these Shh-induced cellu-
lar responses have been identified. Cyclin D1, the major 
D-type cyclin expressed in the retina, is a reported target of 
Shh signaling during retinal development (  Wang et al., 2005  ; 
  Locker et al., 2006  ). However, loss of   Cyclin D1   in the retina 
does not recapitulate the cell fate changes observed with loss 
of Shh signaling (  Ma et al., 1998  ), which indicates that other 
unidentifi  ed targets of Shh/Gli signaling are necessary for 
establishing Shh-dependent effects. 
  Hes1 is a basic helix-loop-helix (bHLH) repressor and 
functions as a target of Notch signaling, a pathway that 
plays a key role in maintaining neural progenitor identity 
(  Kageyama et al., 2005  ). There are several redundant func-
tions of Shh and Hes1 during CNS and retinal development 
that suggest convergence of these pathways. For example, 
Hes1 has been implicated in regulating cell cycling in the 
chick retina and M  ü  ller cell development in the mouse retina 
(  Furukawa et al., 2000  ;   Takatsuka et al., 2004  ;   Hashimoto 
et al., 2006  ). Also, the retinas of   Hes1   and   Shh   mutants  are 
phenotypically similar, as both are characterized by an in-
creased production of RGCs, precocious cell cycle exit, and 
depletion of RPCs (  Takatsuka et al., 2004  ;   Wang et al., 2005  ). 
In contrast, conditional   Notch1   mouse mutants are character-
ized by a propensity to develop cone photoreceptors without 
an increase in RGC development (  Jadhav et al., 2006  ;   Yaron 
et al., 2006  ). The differing phenotypes resulting from loss of 
  Notch   and   Hes1   in the retina suggest that Hes1 may have 
Notch-independent roles in retinal development. Further-
more, preliminary observations indicate that Shh signaling 
may infl  uence the maintenance of   Hes1   expression in the 
retina (  Wang et al., 2005  ). 
  Here, we establish a novel, Shh-dependent regulatory 
mechanism for controlling neural progenitor cell behavior. 
Inhibition of Hes1 activity results in a decrease in RPC pro-
liferation as well as a disruption of neuronal cell develop-
ment in response to Shh pathway activation. Furthermore, 
the increased proliferation characterizing   PtchlacZ  
+/      reti-
nas is rescued in compound   PtchlacZ  
+/     Hes1 
+/        heterozy-
gous mice, which suggests that   Hes1   is epistatic to   Ptch   and 
is required to potentiate the proliferative response induced 
by the Shh pathway in vivo. We show that modulation of 
  Hes1   by Shh requires signaling through the activator Gli2 
and is independent of the Notch pathway. Finally, chromatin 
immunoprecipitation (ChIP) analysis suggests that   Hes1   is  a 
Shh-dependent, direct transcriptional target of Gli2. Thus, 
we have identified a novel mechanism linking Shh, Gli2, 
and Hes1 that is important for controlling neural progenitor 
cell proliferation. 103 GIL2 AND HES1 IN RETINAL NEUROGENESIS   • Wall et al. 
are responsible for mediating Shh-dependent   Hes1   expression. 
We next asked whether the induction of   Hes1   by the Shh pathway 
requires the activity of RBPJ-     by investigating   Hes1   induction 
in the context of RBPJ-     knockdown. To control for the specifi  c-
ity of the shRBPJ-    , we show that Notch (NICD;   Nofziger et al., 
1999  )-mediated activation of a Notch reporter in retinal explants 
is abrogated by coexpression of shRBPJ-     (Fig. S1, available at 
http://www.jcb.org/cgi/content/full/jcb.200805155/DC1). Retinal 
explants from postnatal day 0 (P0) mice were electroporated with 
an shRBPJ-     plasmid and cotransfected with pUb-GFP to local-
ize the transfected cohort of cells.   Gli1   is induced in the presence 
of the control and shRBPJ-     vectors, which indicates activation 
of the Shh pathway (unpublished data). ISH analysis revealed a 
marked reduction in   RBPJ-       mRNA in transfected cells, which 
was also associated with a cell-autonomous reduction of   Hes5  
mRNA, which provides additional confi  rmation of the specifi  city 
of the knockdown (  Fig. 3, f and l  ). ISH for   Hes1   demonstrates 
that   Hes1   is induced in RPCs by the Smo agonist despite   RBPJ-      
knockdown (  Fig. 3 i  ). However, the Shh pathway is unable to in-
duce   Hes5   in cells expressing the shRBPJ-     construct (  Fig. 3 l  ). 
This result infers a differential mechanism for the modulation of 
  Hes1   and   Hes5   by Shh signaling. The induction of   Hes1   via Shh 
is independent of the Notch signaling pathway, whereas induc-
tion of   Hes5   requires functional RBPJ-     signaling. 
  Activated Notch signaling is a weak 
regulator of Hes1 in RPCs 
  Because Shh-mediated induction of   Hes1   is independent of 
Notch signaling, we wanted to compare the effi  ciency of the 
cells in electroporated retinal explants is very low, which indicates 
that dividing cells are the primary targets for electroporation 
(  Matsuda and Cepko, 2004  ). Retinal explants were coelectro-
porated with Smo-M2 and pUb-GFP to localize the transfected 
cells, and simultaneously treated with DAPT for Notch pathway 
inactivation. In situ hybridization (ISH) for   Gli1   confi  rmed Shh 
pathway activation in response to Smo-M2 (  Fig. 2, f and h  ). 
Induction of Shh signaling with SMO-M2 resulted in a cell-
autonomous increase in   Hes1   and   Hes5   mRNA in the presence of 
DAPT, which indicates that Shh activation of these genes is in-
dependent of the NICD (  Fig. 2, l and p  ). It is also noteworthy that 
control retinal explants electroporated with pUb-GFP, which do 
not exhibit Shh signaling, do not have detectable   Hes1   expression 
(  Fig. 2 i  ). Because endogenous   Hes5   expression is lost with DAPT 
treatment, this suggests that Notch signaling is active in control 
retinal explants yet insuffi  cient to maintain   Hes1   expression. 
  We also tested whether Shh activation can induce cellular 
proliferation in RPCs independently of Notch signaling. Retinal 
explants were electroporated with SMO-M2, treated with DAPT, 
dissociated, and scored for BrdU incorporation. Antagonizing 
Notch activity did not signifi  cantly affect the proliferative effect 
of Shh signaling, which indicates that Shh can regulate progeni-
tor cell behavior in a Notch-independent manner (  Fig. 2 q  ). 
  Differential mechanism for the induction of 
Hes1 and Hes5 by Shh signaling 
  Although the previous experiment (  Fig. 2  ) demonstrates that Shh 
can regulate   Hes1   independently of NICD activity, it does not ad-
dress whether other downstream effectors of the Notch pathway 
  Figure 1.       Shh is required to maintain Hes1 protein and mRNA in postnatal retinal explants.   (a) Diagram of the retinal explant culture method. Once the 
retina is surgically detached from the lens and surrounding ocular tissues, it is ﬂ  attened by making four incisions and cultured on a membrane in the pres-
ence of a Smo agonist to activate the Hh signaling pathway. A cross section of a postnatal retinal explant is shown demonstrating   Gli1   transcript expression 
in the Hh-responsive progenitor cells of the neuroblast region. The RGC layer is comprised of a population of postmitotic neurons that are not responsive to 
Hh signaling. Bar, 100   μ  m. (b) Retinal explants were treated with and without a Smo agonist at E14 (  n   = 3) and P0 (  n   = 3) for 3 d in culture and analyzed 
for   Hes1  ,   Hes5  , and   Gli1   mRNA by RT-qPCR. Values represent fold mRNA induction in Smo agonist  –  treated explants relative to untreated explants. Error 
bars represent SEM. *, P   <   0.05. (c) Western blot for Hes1 from P0 retinal explants cultured for 3 d from untreated and Smo agonist  –  treated explants; 
    -tubulin protein level was used as a loading control.     JCB • VOLUME 184 • NUMBER 1 • 2009  104
we generated  Gli1 
   /     ,  Gli2 
   /     , and  Gli1 
   /   Gli2 
   /      mutant mice. 
Retinal explants derived from these mice were cultured in the 
presence of Smo agonist and analyzed by RT-qPCR for induc-
tion of   Hes1   mRNA. The Hh-mediated induction of   Hes1   was 
reduced fourfold in   Gli2 
   /       explants compared with wild-type 
explants, whereas loss of Gli1 signaling did not effect   Hes1   in-
duction (  Fig. 4 a  ). These data indicate that Gli2 is the predomi-
nate factor responsible for   Hes1   regulation downstream of Shh 
activation. However,   Hes1   induction was completely attenuated 
in retinal explants cultured from   Gli1 
   /   Gli2 
   /       compound mu-
tant mice in response to Hh pathway activation, which indicates 
that Gli1 can minimally compensate for   Hes1   activation in the 
absence of Gli2 signaling (  Fig. 4 a  ). To establish a link between 
Gli2 signaling and   Hes1   expression in vivo, we analyzed en-
dogenous levels of   Hes1   in acutely dissected   Gli2 
   /       and wild-
type E18 retinas (  Fig. 4 b  ).   Hes1   expression is down-regulated 
nearly threefold in   Gli2 
   /       retinas compared with wild-type ret-
inas, which establishes Gli2 as an important regulator of   Hes1  
expression in vivo. 
Shh and Notch pathways in activating   Hes1   in RPCs. The 
active NICD, Smo-M2, or an empty-vector control were co-
electroporated with pUB-GFP in retinal explant cultures. 
  Hes1   expression was analyzed using RT-qPCR and normal-
ized to GFP to account for variations in transfection effi  -
ciency. Activation of the Hh pathway resulted in a 10-fold 
greater   Hes1   induction compared with Notch pathway acti-
vation (  Fig. 3 m  ), which indicates that   Hes1   expression in 
RPCs is primarily responsive to the Shh pathway when com-
pared with Notch signaling. 
  Shh induction of Hes1 requires signaling 
through activator Gli2 
  The major downstream activators of the Shh pathway are the 
Gli1 and Gli2 transcription factors, which activate target gene 
expression in response to Smo signaling (  Park et al., 2000  ; 
  Bai et al., 2002  ).   Gli1   and   Gli2   are also expressed in the Hh-
responsive neuroblast region of the developing retina. To evaluate 
the role of activator Gli function in the regulation of   Hes1 , 
  Figure 2.       Shh activation of   Hes1   and   Hes5   is independent of Notch signaling.   Retinas at P0 were electroporated with SMO-M2 cotransfected with pUB-
GFP or pUB-GFP alone and cultured for 3 d with DAPT or DMSO control. (a  –  d) GFP ﬂ  uorescence localizes the transfected cells. ISH was performed for   Gli1   
(e  –  h),   Hes1   (i  –  l), and   Hes5   (m  –  p). Differences in the localization of transfected cells within the explants are caused by folding and twisting during tissue 
processing. Bars, 100   μ  m. (q) Retinal explants (P0 + 3 days in vitro [DIV]) were electroporated with Smo-M2/pUb-GFP, treated with DAPT, dissociated, 
and scored for the proportion of BrdU+GFP+/GFP+ cells. The magnitude of Smo-M2  –  induced proliferation is not changed with DAPT treatment. Error bars 
represent SEM. *, P   <   0.05; **, P   <   0.005.     105 GIL2 AND HES1 IN RETINAL NEUROGENESIS   • Wall et al. 
lyzed for association with Gli2 in control and Smo agonist  –
  treated retinal explants. Validation of the specifi  city of the 
Gli2 antibody used for ChIP analysis was tested by Western 
blotting using COS cells transfected with a full-length   Gli2  
expression plasmid or a GFP control plasmid (  Fig. 4 c  ). 
Physical association of Gli2 at the   Hes1   promoter was de-
tected at two putative Gli consensus sequences located at 
    146 bp and     7,808 bp upstream of the transcription start 
site (  Fig. 4 d  ). Enrichment for Gli2 at the   Hes1   promoter  was 
only detected in Smo agonist  –  treated explants, with no en-
richment of Gli2 detected in untreated explants, which sug-
gested that   Hes1   is a Shh-dependent direct transcriptional 
target of Gli2 (  Fig. 4 d  ). 
  The observation that Gli2 binds the   Hes1   promoter only in 
the presence of Shh signaling may be attributed to the stability of 
Gli protein (  Huntzicker et al., 2006  ;   Pan et al., 2006  ). To test this 
hypothesis, we investigated whether we can detect endogenous 
  Because the induction of   Hes1   by Shh does not require 
signaling through Notch but does require Gli2, we addressed 
whether   Hes1   is a direct transcriptional target of Gli2. To 
study Hes1 regulation in vitro, we generated a luciferase re-
porter containing the   Hes1   promoter and 10 kb of additional 
upstream sequence. The   Hes1   reporter is not suffi  cient  to 
mimic endogenous  Hes1  activity by Hh signaling, which could 
indicate that we have not identifi  ed all of the relevant regula-
tory sequences or that the function of Gli2 in this context will 
not be revealed in simple reporter assays with nonchroma-
tinized substrates (  Kleinjan and van Heyningen, 2005  ;   Ni et al., 
2008  ). We therefore examined the possibility of Shh-mediated 
regulation of   Hes1   in the context of native chromatin by per-
forming ChIP. These experiments allowed us to determine 
whether Gli2 binds the   Hes1   promoter in a physiologically 
relevant context. Candidate Gli consensus sequences were 
identifi  ed within a 10-kb region of the   Hes1   promoter and ana-
  Figure 3.       RBPJ-     signaling is not required for Shh induction of   Hes1   but is necessary for Shh induction of   Hes5  .   Retinal explants were electroporated with 
shRBPJ-     or a control short hairpin plasmid at P0 and cultured for 4 d with or without a Smo agonist. (a  –  c) GFP ﬂ  uorescence localizes the transfected cells. 
ISH was performed for   RBPJ-       (d  –  f),   Hes1   (g  –  i), and   Hes5   (j  –  l). Bar, 100   μ  m. (m) Retinal explants were coelectroporated with an empty vector control, 
NICD, or Smo-M2 and pUB-GFP, and cultured for 3 d, then   Hes1   expression was analyzed by RT-qPCR. Values represent the relative induction of   Hes1   
expression normalized to GFP. Error bars represent SEM. *, P   <   0.005.     JCB • VOLUME 184 • NUMBER 1 • 2009  106
  To further explore the relationship between Shh signaling 
and   Hes1   regulation, we examined the kinetics of   Hes1   induc-
tion in retinal explants. Retinal explants treated with a Smo ago-
nist for 6 h exhibited a signifi  cant induction of   Hes1   compared 
with untreated explants, strengthening the evidence of a direct 
relationship between   Hes1   and Hh signaling (  Fig. 4 h  ). This in-
duction of   Hes1   is not caused by decay of Hh signaling in 
Gli2 protein in RPCs in the absence of Hh signaling. Western 
blot analysis revealed that Gli2 protein is only detected in cul-
tures with an active Hh pathway despite the presence of Gli2 
transcript in untreated retinal explants (  Fig. 4, e  –  g  ). This data 
indicates that Hh signaling is necessary for the stability of Gli2 
protein in RPCs and accounts for the Hh-dependent binding of 
Gli2 to the   Hes1   promoter. 
  Figure 4.       Shh induction of   Hes1   requires Gli2.   (a) Retinal explants were cultured from wild-type (Wt;   n   = 5),   Gli1 
    /        (  n   = 3),   Gli2 
    /        (  n   = 6), and 
  Gli2 
    /     Gli1 
    /        (  n   = 3) mice with or without a Smo agonist at E18 for 3 d, then analyzed for   Hes1   expression by RT-qPCR. Values represent fold mRNA 
induction in Smo agonist  –  treated explants relative to untreated explants. (b) RT-qPCR on acutely dissected retinas from E18 wild-type (  n   = 5) and   Gli2 
    /        
(  n   = 5) animals. Values represent fold mRNA induction in   Gli2 
    /        retinas compared with the wild type. The black lines in the Western blot indicate that 
intervening lanes have been spliced out. (c) Western blot analysis of protein lysates from Myc-Gli2  –  transfected or control COS cells blotted with an anti-Gli2 
antibody. The     -tubulin protein level was used as a loading control. (d) Schematic of the 10-kb region of the   Hes1   promoter. The Gli2-binding sites are indi-
cated with the mismatched nucleotides relative to the ideal Gli consensus sequence in small letters. ChIP reveals enrichment of Gli2 at sites     7,808 bp and 
    146 bp upstream of the transcription start site in the   Hes1   promoter in retinal explants treated with a Smo agonist. No enrichment of Gli2 was detected 
at these sites in untreated retinal explants. Association of Gli2 at a region of the   Hes1   promoter that does not contain a Gli consensus sequence was used 
as a negative control. (e) Western blot analysis for Gli2 on retinal explants treated with or without a Smo agonist (P0 + 3 DIV). The     -tubulin protein level 
was used as a loading control. (f and g) Retinal explants cultured with or without a Smo agonist for 3 DIV and subjected to ISH for   Gli2  . Bars, 100   μ  m. 
(h) Retinal explants (P0) were cultured with (  n   = 5) or without a Smo agonist (  n   = 4) for 6 h and analyzed for   Hes1   and   Gli1   expression by RT-qPCR. Values 
represent fold mRNA induction in Smo agonist  –  treated explants relative to untreated explants. Error bars represent SEM. *, P   <   0.05; **, P   <   0.001.     107 GIL2 AND HES1 IN RETINAL NEUROGENESIS   • Wall et al. 
Hes1DN-expressing cohort compared with the GFP-expressing 
cells (  Fig. 5 g  ), which indicates that Hes1 is required for Shh-
mediated proliferation. This data also reinforces the hypothesis that 
Hes1 is a Notch-independent target of Shh, as inhibition of Notch 
signaling did not compromise Shh-induced proliferation (  Fig. 2 q  ). 
  The Shh pathway also promotes the development of M  ü  ller 
glia and bipolar cells at the expense of rod photoreceptors (Fig. S3; 
  Wang et al., 2005  ;   Yu et al., 2006  ). As Hes1 has been implicated 
as a regulatory factor in promoting bipolar and M  ü  ller cell specifi  -
cation (  Tomita et al., 1996  ;   Furukawa et al., 2000  ;   Takatsuka 
et al., 2004  ), we investigated whether Hes1 was required for the 
acquisition of specifi  c cell fates downstream of Shh signaling. 
Retinal explants were electroporated with the Hes1DN con-
struct or GFP, cultured with the Smo agonist for 7 d in vitro, and 
dissociated and scored using IHC for specifi  c cell type markers. 
Signifi  cantly, there was a 50% reduction in the proportion of 
M  ü  ller (anti-cellular retinaldehyde-binding protein [CRALBP]) 
and bipolar cells (anti  –  Chx10) in agonist-treated Hes1DN-
expressing cells compared with agonist-treated GFP-expressing 
cells (  Fig. 5 g  ). The reduction in cells with a bipolar and M  ü  ller 
cell identity in the Hes1DN cohort was associated with an in-
crease in the proportion of cells positive for rod photoreceptor 
markers rhodopsin and recoverin. Therefore, the M  ü  ller- and 
bipolar-promoting effects of Shh require Hes1. 
  Loss of Gli2 represses proliferation and 
cell fate speciﬁ  cation in response to Shh 
signaling, similar to inhibition of Hes1 
  Because Gli2 is necessary for the induction of Hes1 by Shh sig-
naling, we asked whether loss of Gli2 phenocopies the effect of 
Hes1 inhibition in the context of an activated Shh pathway. 
  Gli2 
   /       mutant explants at E18 were cultured with the Smo ago-
nist and analyzed for proliferation and the development of spe-
cifi  c cell types. Proliferation was attenuated in   Gli2 
   /     -treated 
explants relative to wild type  –  treated explants after 3 d (  Fig. 6  ). 
M  ü  ller and bipolar cell development was also reduced in 
  Gli2 
   /      -treated explants cultured for 7 d compared with control 
explants (  Fig. 6  ), which demonstrates that Gli2 is required for 
Shh effects on cell type development. In contrast, Hh-mediated 
proliferation was normal in the absence of   Gli1   correlating  with 
normal   Hes1   induction (unpublished data). 
  Discussion 
  In this study, we sought to identify the molecular mechanisms 
that Shh utilizes to regulate CNS progenitor cell behavior. We 
have used the neural retina as a model for CNS development 
to evaluate the mechanism and function of   Hes1   as a putative 
Shh target gene.   Hes1   is a key target of the Notch pathway, and 
its role during development is normally associated with acti-
vated Notch signaling. However,   Hes1   mutant retinas do not 
mimic   Notch1   mutants, which suggests that Hes1 may have 
Notch-independent roles in retinal development (  Takatsuka et al., 
2004  ;   Jadhav et al., 2006  ;   Yaron et al., 2006  ). This idea is cor-
roborated by the persistent expression of   Hes1   in   Notch1   and 
  RBPJ-       mutant embryos and the identifi  cation of other factors 
capable of activating   Hes1   (  de la Pompa et al., 1997  ;   Furukawa 
untreated explants because retinal explants cultured for 6 h do 
not exhibit a signifi  cant decrease in levels of   Gli1   or   Hes1   when 
compared with acutely dissected retinas (Fig. S2, available at 
http://www.jcb.org/cgi/content/full/jcb.200805155/DC1). 
  Hes1 is necessary for Shh-mediated 
proliferation and cell fate speciﬁ  cation 
in RPCs 
  Because we have demonstrated a novel mechanism for   Hes1  
regulation by Shh-Gli2 signaling, we wanted to examine the 
physiological signifi  cance of   Hes1   as a Shh target gene. To in-
vestigate this, we used   PtchlacZ 
+/        mice, which exhibit consti-
tutive Hh pathway activation that results in delayed cell cycle 
exit in the central retina of postnatal mice (  Black et al., 2003  ; 
  Moshiri and Reh, 2004  ). To directly evaluate whether   Hes1   is 
necessary for the Hh-mediated proliferation of progenitor cells 
in vivo, we generated   PtchlacZ  
+/     Hes1 
+/        compound  heterozy-
gous mice. We chose to work with mice heterozygous for   Ptch  
because   Ptch 
   /       mutants exhibit early embryonic lethality be-
fore retinal development (  Goodrich et al., 1997  ). Immunohisto-
chemistry (IHC) for the mitotic marker pH3 revealed that 
mitotic cells were reduced in the compound heterozygous reti-
nas (  PtchlacZ  
+/     Hes1 
+/       ) compared with retinas from   PtchlacZ 
+/       
mice (  Fig. 5, a  –  c  ). Furthermore, quantifi  cation of BrdU incor-
poration from retinal sections of   PtchlacZ  
+/     Hes1 
+/        double 
heterozygous animals revealed a signifi  cant reduction in the 
total number of cells in S phase compared with  PtchlacZ  
+/     retinas, 
which demonstrates that Hes1 is a mediator of Shh-dependent 
proliferation in the retina in vivo (  Fig. 5 d  ). Also, quantifi  cation 
of the proportion of BrdU-labeled cells from dissociated retinas 
revealed a signifi  cant increase in proliferation in   PtchlacZ  
+/     
retinas compared with the wild type; however, there was no sig-
nifi  cant increase in proliferation in   PtchlacZ  
+/     Hes1 
+/        retinas 
(  Fig. 5 e  ). This data provides novel evidence for an in vivo 
genetic interaction between Hh signaling and   Hes1   in the regu-
lation of progenitor cell proliferation. 
  We also investigated the proliferative response induced by 
Shh in   Hes1 
   /       mutant retinal explants. Loss of   Hes1   resulted  in 
a signifi   cant decrease in Shh-mediated BrdU incorporation 
compared with wild-type explants (  Fig. 5 f  ). To study whether 
acute inhibition of Hes1 activity antagonizes progenitor cell 
proliferation in response to Shh, we antagonized Hes1 activity 
using a previously characterized Hes1DN construct that carries 
three point mutations in the basic DNA-binding domain that in-
terfere with its DNA-binding activity (  Strom et al., 1997  ). The 
Hes1DN protein will dimerize with wild-type Hes1 and HesR 
proteins to form transcriptionally inactive complexes. Retinal 
explants were electroporated with the Hes1DN construct and cul-
tured in the presence of a Smo agonist for 3 d in vitro. The ex-
plants were dissociated by enzymatic digestion followed by IHC 
for cell type – specifi  c markers and scored for marker+ cells among 
the transfected cohort of cells, which was identifi  ed by GFP fl  uor-
escence. Normally, Smo agonist treatment of control electro-
porated RPCs results in an increased proportion of dividing 
progenitors compared with control explants (Fig. S3, available at 
http://www.jcb.org/cgi/content/full/jcb.200805155/DC1). BrdU 
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itors. Surprisingly, we have observed a differential mechanism 
for Shh-mediated regulation of   Hes1   and   Hes5  . Induction of 
  Hes5   is independent of Notch; however, it requires signaling by 
RBPJ-    , suggesting that RBPJ-     can function independently of 
Notch downstream of Shh activation. To date, Notch-independent 
RBPJ-     activity has only been reported in   Drosophila melano-
gaster   mechanoreceptor physiology, mouse pancreas develop-
ment, and the specifi  cation of GABAergic neurons (  Barolo 
et al., 2000  ;   Beres et al., 2006  ;   Hori et al., 2008  ). 
  The requirement for both Shh- and Notch-driven re-
gulation of   Hes1   in progenitor cells may be explained by 
et al., 2000  ;   Stockhausen et al., 2005  ;   Nguyen et al., 2006  ; 
  Ingram et al., 2008  ;   Nakazaki et al., 2008  ). Also, inhibition of 
the Notch pathway in chick retinal explants results in a weak 
reduction of   Hes1   expression and a much more potent reduction 
in   Hes5   levels, which is further evidence for Notch-independent 
  Hes1   regulation (  Nelson et al., 2007  ). Shh treatment of cerebel-
lar granule precursors results in induction of   Hes1  , which sug-
gests a more general role for Shh in the regulation of   Hes1   in 
CNS development (  Solecki et al., 2001  ). Here, we show that 
Gli2 is a novel regulator of   Hes1   expression and that Hes1 is a 
novel mediator of Shh-mediated proliferation in neural progen-
  Figure 5.       Shh-mediated RPC proliferation and cell fate speciﬁ  cation requires   Hes1  .   (a  –  c) In vivo anti-pH3 staining of the central retina adjacent to the 
optic nerve (asterisks) in P5 wild-type (Wt),   PtchlacZ 
+/       , and   PtchlacZ 
+/     Hes1 
+/        retinas. Arrows indicate pH3-positive cells. Note that pH3+ cells in the 
vicinity of the optic nerve are rare in Wt and compound heterozygous mice. Bar, 100   μ  m. (d) Quantitative analysis of BrdU incorporation in vivo from P5 
Wt (  n   = 3),   Hes1 
+/        (  n   = 3),   PtchlacZ 
+/        (  n   = 3), and   PtchlacZ 
+/     Hes1 
+/        (  n   = 6) retinas. Values represent the mean number of BrdU-positive cells counted 
from three sections per animal. (e) Quantiﬁ  cation of the proportion of BrdU 
+   cells in single-cell dissociates from the retinas of Wt (  n   = 5),   Hes1 
+/        (  n   = 
3),   PtchlacZ 
+/        (  n   = 8), and   PtchlacZ 
+/     Hes1 
+/        (  n   = 7) retinas at P5. (f) Retinal explants from   Hes1 
    /        (  n   = 3) or Wt (  n   = 3) animals were treated with a 
Smo agonist for 3 d, dissociated, and scored for the proportion of BrdU 
+  DAPI 
+   cells. (g) Quantitative analysis for BrdU, CRALBP, Chx10, rhodopsin, and 
recoverin-positive cells in Smo agonist  –  treated P0 retinal explants electroporated with GFP and Hes1DN. Values are based on scoring marker+ cells 
among the transfected cohort in dissociates from retinal explants and represent the fold induction of double-positive (marker+GFP+) cells in GFP + Ag and 
Hes1DN + Ag cultures compared with double-positive cells in GFP-transfected untreated explants. There is no difference in proliferation or cell type composi-
tion in GFP and Hes1DN-transfected cells in untreated explants. Error bars represent SEM. *, P   <   0.05; **, P   <   0.01.     109 GIL2 AND HES1 IN RETINAL NEUROGENESIS   • Wall et al. 
duction of   Hes1  , it appears that derepression of Gli3 is not a 
primary regulator in this context. 
 Hh control of  Hes1  appears to be an evolutionary conserved 
signaling mechanism involved in widespread tissue patterning. 
Hh drives expression of the  D. melanogaster  homologue of  Hes1 , 
  hairy  , along the dorsal/ventral axis of the leg imaginal disc to 
negatively regulate the development of sensory cell fates (  Hays 
et al., 1999  ). The induction of   hairy   in response to Hh requires Cu-
bitus interruptus (Ci), the  D. melanogaster  homologue of Gli, and 
dorsal/ventral expression of   hairy   is lost in Smo-defi  cient clones 
(  Hays et al., 1999  ). Patterning of the retinal fi  eld during develop-
ment of the   D. melanogaster   compound eye also reveals Notch-
independent regulation of hairy by Hh (  Fu and Baker, 2003  ). In 
this system, both Hh and Notch negatively regulate   hairy   expres-
sion to promote a wave of photoreceptor differentiation. 
  In this study, we have elucidated a novel mechanism for 
Shh-controlled progenitor cell behavior. Our observation that 
Gli2 occupies the   Hes1   promoter is one of the fi  rst identifi  ed di-
rect relationships between Gli2 and a target gene in neural pro-
genitor cells. This study provides a mechanistic link between 
Shh-Gli2 signaling and Hes1 in regulating the proliferation of 
RPCs, thereby shedding light on a new means of manipulating 
Shh-induced cellular responses. 
  Materials and methods 
  Transgenic mice 
  Several transgenic mouse lines were used in this study.   PtchlacZ 
+/        mice 
(  Goodrich et al., 1997  ) were obtained from the Jackson Laboratory and 
maintained on a C57Bl6 background;   Gli1 
+/        and   Gli2 
+/        mice (obtained 
from A. Joyner, Sloan-Kettering Institute, New York, NY;   Mo et al., 1997  ; 
  Park et al., 2000  ), and   Hes1 
+/        (  Ishibashi et al., 1995  ) were maintained 
on a CD1 background.   PtchlacZ 
+/       were crossed with   Hes1 
+/        mice to 
generate double heterozygous mice (  PtchlacZ 
+/     Hes1 
+/       ).   Gli1 
+/        and 
  Gli2 
+/        strains were mated to generate double heterozygous animals, 
  Gli1 
+/     Gli2 
+/       , which were subsequently crossed to give double homo-
zygous null mice   Gli1 
    /     Gli2 
    /       . Unless otherwise stated, retinal explants 
were derived from CD1 (the Jackson Laboratory) wild-type mice. 
  Cell culture, retinal explants, and BrdU labeling 
  Mouse strains were continuously mated or time-mated to generate speci-
mens of the appropriate age, with the day of the vaginal plug designated 
day 0 of gestation. Retinal explants were prepared as described previously 
(  Wang et al., 2005  ). Retinal explant medium was supplemented with 10 nM 
of Smo agonist (Ag1.10; a kind gift from Curis, Inc.;   Frank-Kamenetsky 
et al., 2002  ) or 10   μ  M DAPT (Millipore), then cultured at 8% CO  2   and 
37  °  C. Selected explants were labeled with 10   μ  M BrdU for the last 6 h of 
several hypotheses. First, Shh and Notch could be targeting dif-
ferent progenitor populations. A recent study has shown that the 
activated NICD is heterogeneously expressed in subsets of pro-
genitors in the mouse retina (  Nelson et al., 2007  ), which implies 
that not all progenitors are responsive to activated Notch signaling. 
Second, progenitor cells are sensitive to Hes1 dosage; therefore, 
Notch and Shh signaling may be required to achieve the spec-
trum of Hes1 levels needed for cell fate specifi  cation and prolif-
eration. For example,   Hes1 
+/        retinas exhibit accelerated rod 
photoreceptor differentiation without the proliferative or RGC 
phenotype characterizing   Hes1 
   /       retinas (  Takatsuka et al., 
2004  ). Also, the decision to adopt an RGC fate is dependent on 
levels of proneuronal bHLHs NGN2 and Math5 as well as Hes1, 
with high levels of Hes1 antagonizing Math5 expression and 
function and thereby inhibiting the RGC fate (  Matter-Sadzinski 
et al., 2005  ). Mechanistically, oscillation in Hes1 expression 
(  Hirata et al., 2002  ) could be one way to achieve functionally 
relevant modulations in Hes1 levels in progenitor cells. Notch-
induced Hes1 oscillation is required for the maintenance of neu-
ral progenitors (  Shimojo et al., 2008  ), and it is conceivable that 
the effects of Hh signaling on Hes1 expression could be medi-
ated by a similar mechanism. Further analysis is necessary to 
determine the mode of Hes1 expression in the context of Hh 
pathway activation. 
 We  have  identifi  ed a direct interaction of Gli2 and   Hes1   at 
two Gli consensus sites in the   Hes1   promoter. In these studies, 
we obtained strong evidence for a direct effect because ChIP 
analysis using primary RPCs revealed Shh-dependent recruit-
ment of Gli2 to the   Hes1   promoter in vivo. These fi  ndings, cou-
pled with our strong genetic evidence linking Shh to   Hes1 , 
provide the fi  rst example of an interaction between Gli2 signal-
ing and   Hes1   expression, and the fi  rst example of the impor-
tance of this mechanism in the regulation of progenitor cell 
proliferation. Our fi  ndings also raise the possibility that Gli2-
dependent regulation of proliferation in other tissues could 
function with a similar mechanism (  Matise et al., 1998  ; 
 Corrales et al., 2004 ;  Palma and Ruiz i Altaba, 2004 ;  Hutchin et al., 
2005  ;   Hu et al., 2006  ;   Zhang et al., 2008  ). In addition to activa-
tor Gli1 and Gli2 function, the Gli3 transcription factor is also a 
mediator of the Shh pathway, and it functions to repress target 
genes in the absence of Shh signaling. Because loss of function 
of both Gli1 and Gli2 completely attenuates Shh-mediated in-
  Figure 6.       Gli2 is required for the Shh effects 
on proliferation and cell fate.   Retinal explants 
were cultured from wild-type (Wt;   n   = 3) and 
  Gli2 
    /        (  n   = 3) mice at E18 for 3 d in culture 
with or without a Smo agonist. IHC was per-
formed on dissociated cells using anti-BrdU, 
anti-CRALBP, anti-rhodopsin, and anti-recoverin 
antibodies. Values represent the fold induction of 
positive cells in Wt + Ag or   Gli2 
    /        + Ag cul-
tures compared with nontreated explants. Error 
bars represent SEM. *, P   <   0.05; **, P   <   0.01.     JCB • VOLUME 184 • NUMBER 1 • 2009  110
GCCTCACACCT-3    ; reverse, 5    -GTACTCGGTTCGGCTTCTCC-3    ). The 
PCR reaction was performed on a MX3000P (Stratagene) with 40 ampliﬁ  -
cation cycles. Changes in gene expression were quantiﬁ  ed based on the 
2 
    Ct   value normalized to 18S. Normalization to GFP was used to standard-
ize for transfection efﬁ  ciency in electroporated retinal explants. Statistical 
signiﬁ  cance was determined using a two-tailed student  ’  s   t   test. 
  ChIP 
  Candidate Gli consensus sequences were identiﬁ  ed as GACCACCCA or 
TGGGTGGTC (  Lai et al., 2004  ), and primers were designed to amplify 
regions of genomic DNA that contain at least a seven-base match within 
a 10-kb region of the Hes1 promoter. CD1 retinal explants treated with 
or without a Smo agonist for 3 d were ﬁ  xed in cold 4% paraformalde-
hyde PBS solution (two explants per condition) for 30 min. The DNA was 
sheared to less than 1 kb by sonication. ChIP was performed using the EZ 
ChIP kit (Millipore) according to the manufacturer  ’  s instructions. Immuno-
precipitations were performed using 10   μ  l of a goat anti-Gli2 polyclonal 
antibody (Santa Cruz Biotechnology, Inc.) or an irrelevant antibody of the 
same species (goat anti-Brn3b). DNA was analyzed using qPCR with 
2   μ  l of DNA with Brilliant SyBr green mastermix (Stratagene) and 200 nM 
of Hes1 primers (    7,808 bp site: forward, 5    -CAGTGCTACAGACCA-
CACAGG-3    ; and reverse, 5    -AGAACGTGACATCGGCTTTC-3    ;     146 
bp site: forward, 5    -TCCTTTTGATTGACGTTGTAGC-3    ; and reverse, 
5    -CCCAAACTTTCTTTCCCACA-3    ), with an annealing temperature of 
60  °  C on a MX3000P for 40 cycles. A primer set (forward, 5    -TTGAGGG-
TTTTTGTTTTGTTTTG-3    ; reverse, 5    -CGGTTGCTTTTTAAACAGTGG-3    ) 
spanning a region of the Hes1 promoter without a Gli consensus sequence 
was used as a negative control. The Ct values were expressed relative to 
unprecipitated input chromatin and fold enrichment were calculated by 
2 
    Ct  , where     Ct = Ct (anti-Gli2   –   anti-control Brn3b). Standard deviation 
was calculated based on three independent experiments, and signiﬁ  cance 
was calculated using a two-tailed student  ’  s   t   test. 
  Online supplemental material 
  Fig. S1 shows knockdown of Hes1 reporter activity in response to shRBPJ-    . 
Fig. S2 conﬁ  rms that   Hes1   and   Gli1   levels are maintained in retinal explant 
cultures after a culture period of 6 h. Fig. S3 shows the proportions of retinal 
cell types in response to Smo Ag treatment. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200805155/DC1. 
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culture to identify cells in S phase. Explants were either ﬁ  xed in a 4% para-
formaldehyde phosphate buffer for 1 h, transferred to a 30% sucrose/PBS 
solution overnight, and embedded in 1:1 optimal cutting temperature/30% 
sucrose/PBS mixture or dissociated into single cells with trypsin (Sigma-
Aldrich) and plated onto Superfrost slides (Sigma-Aldrich) for quantitative 
analysis as described previously (  Wang et al., 2005  ). COS cells were cul-
tured in 10% FBS DME and transfected with full-length Myc-tagged Gli2 
(a gift from H. Sasaki, RIKEN Center for Developmental Biology, Chuo-ku, 
Kobe, Japan;   Sasaki et al., 1999  ) or pUb-GFP (a gift from T. Matsuda, 
Harvard Medical School, Boston, MA) using Lipofectamine 2000 (Invitro-
gen) according to the manufacturer  ’  s instructions. 
  Histology, IHC, and ISH 
  IHC or ISH was performed as described previously (  Jensen and Wallace, 
1997  ;   Wallace, 1999  ;   Dakubo et al., 2003  ). Antibodies used in this 
study include rabbit polyclonal anti-CRALBP (a kind gift from J. Saari, 
University of Washington, Seattle, WA), mouse monoclonal anti-BrdU 
(BD), mouse monoclonal anti-rhodopsin (  R  ö  hlich et al., 1989  ), rabbit 
polyclonal anti-recoverin (Millipore), sheep polyclonal anti-Chx10 (a gift 
from R. Bremner, Toronto Western Research Institute, Toronto, Ontario, 
Canada), rabbit polyclonal phosphohistone H3 (Millipore), and rabbit 
polyclonal anti-GFP (Invitrogen). Secondary antibodies include donkey 
anti  –  goat IgG Cy3 (Invitrogen), goat anti  –  rabbit IgG FITC (Invitrogen), 
goat anti  –  mouse IgG Cy3 (Jackson ImmunoResearch Laboratories), and 
goat anti  –  rabbit IgG Cy3 (Jackson ImmunoResearch Laboratories). The 
antisense riboprobes used for ISH include Gli1 (a gift from A. Joyner), 
RBPJ-     (a gift from T. Hongo, Kyoto University, Kyoto, Japan), Gli2 (a gift 
from H. Sasaki), Hes1, and Hes5. Bright ﬁ   eld images were analyzed 
using an Axioplan microscope and captured with an Axiovision camera 
(2.05; both from Carl Zeiss, Inc.). Pictures were taken at magniﬁ  cations 
of 10  ×   (NA 0.30) and 20  ×   (NA 0.05; both from Carl Zeiss, Inc.). Fluor-
escent images were analyzed using an Axiocam microscope (HRm) and 
captured with an Axioimager camera (M1; both from Carl Zeiss, Inc.). 
Florescent images were taken at 20  ×   (0.8 NA). All images were pro-
cessed using Photoshop CS2 (Adobe). 
  In vitro electroporation 
  Electroporation was performed on retinal explants based on the protocol 
from   Matsuda and Cepko (2004)  . Explanted retinas were electroporated 
(ECM 830; BTX Harvard Apparatus) in a 2-mm gap cuvette (VWR) with 
0.5  –  1.5   μ  g/  μ  l of plasmid DNA in endotoxin-free TE buffer with a 10:1 ratio 
of plasmid DNA/pUb-GFP or pUb-GFP alone. The DNA plasmids used 
in this study include: SMO-M2 (a gift from G. Fishell, New York University 
Langone Medical Center, New York, NY), an activated NICD (a gift from 
G. Weinmaster, David Geffen School of Medicine, University of California, 
Los Angeles, Los Angeles, CA), LacZ 2.1 double-stranded shcontrol (Invit-
rogen), shRBPJ-k (Invitrogen), and Hes1DN. 
  Western blotting 
  Protein was extracted from Smo agonist  –  treated and nontreated retinal ex-
plant cultures using RIPA buffer (125 mM Tris-HCL, 2% SDS + protease in-
hibitor cocktail), and Western blotting performed as described previously 
(  Dakubo et al., 2008  ). Protein samples were probed with 1:1,500 rabbit 
polyclonal anti-Hes1 (a gift from N. Brown, University of Cincinnati College 
of Medicine, Cincinnati, OH), 1:200 dilution of goat polyclonal anti-Gli2 
(sc-20291; Santa Cruz Biotechnology, Inc.), 1:500 dilution of rabbit poly-
clonal Gli2 (Abcam), or 1:50 dilution of mouse monoclonal antibody E7 
ascites (Developmental Studies Hybridoma Bank). Secondary antibodies 
used include goat anti  –  rabbit IgG HRP (1:5,000; Sigma-Aldrich), donkey 
anti  –  goat HRP (1:3,000; Santa Cruz Biotechnology, Inc.), and sheep anti  –
  mouse IgG HRP (1:3,000; Sigma-Aldrich). 
  RT-qPCR 
  RNA was harvested from Smo agonist  –  treated and nontreated retinal ex-
plants using Trizol (1 explant per 1 ml of Trizol). cDNA was synthesized using 
2   μ  g of total RNA with the Invitrogen kit according to the manufacturer  ’  s 
instructions. qPCR was performed using 1   μ  l of cDNA with Brillant SyBr 
Green mastermix (Agilent Technologies) according to the manufacturer  ’  s 
instructions, with the exception that the reaction was scaled down to a 
total volume of 25   μ  l. Primers (200 nM) used include Hes1 (forward, 
5    -AAAGACGGCCTCTGAGCACA-3    ; reverse, 5    -TCATGGCGTTGATCT-
GGGTCA-3    ), Hes5 (forward, 5    -AAGAGCCTGCACCAGGACTA-3    ; 
reverse, 5    -CGCTGGAAGTGGTAAAGCA-3    ), and 18S (forward, 5    -CGG-
CTACCACATCCAAGG-3    ; reverse, 5    -CTGGAATTACCGCGGCT-3    ), 
and GFP (forward, 5    -CGTCGCCGTCCAGCTCGACCAG-3    ; reverse, 
5    -CATGGTCCTGCTGGAGTTCGTG-3    ), Gli1 (forward, 5    -CACTACCTG-111 GIL2 AND HES1 IN RETINAL NEUROGENESIS   • Wall et al. 
   Kageyama ,   R. ,  T.    Ohtsuka ,   J.    Hatakeyama ,  and   R.    Ohsawa .   2005 .   Roles  of  bHLH 
genes in neural stem cell differentiation.       Exp. Cell Res.     306 : 343  –  348 .    
   Kim ,   J. ,   H.H.    Wu ,   A.D.    Lander ,   K.M.    Lyons ,   M.M.    Matzuk ,  and   A.L.    Calof . 
  2005  .   GDF11 controls the timing of progenitor cell competence in devel-
oping retina.       Science   .    308 : 1927  –  1930 .    
   Kleinjan ,   D.A. ,  and  V.    van Heyningen  .   2005  .   Long-range control of gene expres-
sion: emerging mechanisms and disruption in disease.       Am. J. Hum. Genet.   
 76 : 8  –  32 .    
   Lai ,   K. ,   M.J.    Robertson ,  and   D.V.    Schaffer  .   2004  .   The sonic hedgehog signaling 
system as a bistable genetic switch.       Biophys. J.     86 : 2748  –  2757 .  
   Levine ,   E.M. ,   H.    Roelink ,   J.    Turner ,  and   T.A.    Reh .   1997 .   Sonic  hedgehog  pro-
motes rod photoreceptor differentiation in mammalian retinal cells in 
vitro.     J. Neurosci.     17 : 6277  –  6288 .  
   Locker ,   M. ,   M.    Agathocleous ,   M.A.    Amato ,   K.    Parain ,   W.A.    Harris ,  and   M.  
  Perron  .   2006  .   Hedgehog signaling and the retina: insights into the mecha-
nisms controlling the proliferative properties of neural precursors.       Genes 
Dev.     20 : 3036  –  3048 .    
   Ma ,   C. ,   D.    Papermaster ,  and   C.L.    Cepko .   1998  .   A unique pattern of photorecep-
tor degeneration in cyclin D1 mutant mice.       Proc. Natl. Acad. Sci. USA   .  
 95 : 9938  –  9943 .    
   Marti ,   E. ,  and   P.     Bovolenta  .   2002  .   Sonic hedgehog in CNS development: one 
signal, multiple outputs.       Trends Neurosci.     25 : 89  –  96 .    
   Matise ,   M.P. ,   D.J.    Epstein ,   H.L.    Park ,   K.A.    Platt ,  and   A.L.    Joyner .   1998 .   Gli2 
is required for induction of fl  oor plate and adjacent cells, but not most 
ventral neurons in the mouse central nervous system.       Development   .  
 125 : 2759  –  2770 .  
   Matsuda ,   T. ,  and   C.L.    Cepko .   2004 .   Electroporation  and  RNA  interference  in  the 
rodent retina in vivo and in vitro.       Proc. Natl. Acad. Sci. USA   .    101 : 16  –  22 .   
   Matter-Sadzinski ,   L. ,   M.    Puzianowska-Kuznicka ,   J.    Hernandez ,   M.    Ballivet ,  and 
 J.M.    Matter .   2005  .   A bHLH transcriptional network regulating the specifi  -
cation of retinal ganglion cells.       Development   .    132 : 3907  –  3921 .    
   Mo ,   R. ,  A.M.    Freer ,   D.L.    Zinyk ,   M.A.    Crackower ,   J.    Michaud ,   H.H.    Heng ,   K.W.  
 Chik ,   X.M.    Shi ,   L.C.    Tsui ,   S.H.    Cheng ,   et  al .   1997 .   Specifi  c and redun-
dant functions of Gli2 and Gli3 zinc fi  nger genes in skeletal patterning 
and development.       Development   .    124 : 113  –  123 .  
   Moshiri ,   A. ,  and   T.A.     Reh  .   2004  .   Persistent progenitors at the retinal margin of 
ptc+/     mice.     J. Neurosci.     24 : 229  –  237 .    
   Moshiri ,   A. ,   C.R.    McGuire ,  and   T.A.    Reh .   2005 .   Sonic  hedgehog  regulates  pro-
liferation of the retinal ciliary marginal zone in posthatch chicks.       Dev. 
Dyn.     233 : 66  –  75 .    
   Nakazaki ,   H. ,   A.C.    Reddy ,   B.L.    Mania-Farnell ,   Y.W.    Shen ,   S.    Ichi ,   C.    McCabe , 
 D.    George ,   D.G.    McLone ,   T.    Tomita ,  and   C.S.    Mayanil .   2008 .   Key  basic 
helix-loop-helix transcription factor genes Hes1 and Ngn2 are regulated 
by Pax3 during mouse embryonic development.       Dev. Biol.     316 : 510  –  523 .   
   Nelson ,   B.R. ,   B.H.    Hartman ,   S.A.    Georgi ,   M.S.    Lan ,  and   T.A.    Reh .   2007 . 
  Transient inactivation of Notch signaling synchronizes differentiation of 
neural progenitor cells.       Dev. Biol.     304 : 479  –  498 .    
   Nguyen ,   B.C. ,   K.    Lefort ,  A.    Mandinova ,   D.   Antonini ,  V.    Devgan ,   G.    Della  Gatta , 
 M.I.    Koster ,   Z.    Zhang ,   J.    Wang ,   A.    Tommasi  di  Vignano ,   et  al .   2006 . 
  Cross-regulation between Notch and p63 in keratinocyte commitment to 
differentiation.     Genes Dev.     20 : 1028  –  1042 .    
   Ni ,   Z. ,   M.   Abou  El  Hassan ,   Z.    Xu ,   T.   Yu ,  and   R.    Bremner .   2008 .   The  chromatin-
remodeling enzyme BRG1 coordinates CIITA induction through many 
interdependent distal enhancers.       Nat. Immunol.     9 : 785  –  793 .    
   Nofziger ,   D. ,   A.    Miyamoto ,   K.M.    Lyons ,  and   G.    Weinmaster .   1999 .   Notch  sig-
naling imposes two distinct blocks in the differentiation of C2C12 myo-
blasts.     Development   .    126 : 1689  –  1702 .  
   Palma ,   V. ,  and   A.    Ruiz  i  Altaba .   2004 .   Hedgehog-GLI  signaling  regulates  the 
behavior of cells with stem cell properties in the developing neocortex.   
  Development   .    131 : 337  –  345 .    
   Pan ,   Y. ,   C.B.    Bai ,   A.L.    Joyner , and   B.    Wang .   2006 .   Sonic  hedgehog  signaling 
regulates Gli2 transcriptional activity by suppressing its processing and 
degradation.     Mol. Cell. Biol.     26 : 3365  –  3377 .    
   Park ,  H.L. ,  C.   Bai ,  K.A.   Platt ,  M.P.   Matise ,  A.   Beeghly ,  C.C.   Hui ,  M.   Nakashima , 
and   A.L.     Joyner  .   2000  .   Mouse Gli1 mutants are viable but have defects 
in SHH signaling in combination with a Gli2 mutation.       Development   .  
 127 : 1593  –  1605 .  
   R ö hlich ,   P. ,   G.    Adamus ,   J.H.    McDowell ,  and   P.A.    Hargrove .   1989 .   Binding  pat-
tern of anti-rhodopsin monoclonal antibodies to photoreceptor cells: an 
immunocytochemical study.       Exp. Eye Res.     49 : 999  –  1013 .  
   Sasaki ,   H. ,  Y.    Nishizaki ,   C.    Hui ,   M.    Nakafuku ,  and   H.    Kondoh .   1999 .   Regulation 
of Gli2 and Gli3 activities by an amino-terminal repression domain: 
implication of Gli2 and Gli3 as primary mediators of Shh signaling.   
  Development   .    126 : 3915  –  3924 .  
   Shimojo ,   H. ,  T.    Ohtsuka ,  and   R.    Kageyama .   2008  .   Oscillations in notch signaling 
regulate maintenance of neural progenitors.       Neuron   .    58 : 52  –  64 .    
   Corrales ,   J.D. ,   G.L.    Rocco ,   S.    Blaess ,   Q.    Guo ,  and   A.L.    Joyner .   2004 .   Spatial 
pattern of sonic hedgehog signaling through Gli genes during cerebellum 
development.     Development   .    131 : 5581  –  5590 .    
   Dakubo ,   G.D. ,  and   V.A.    Wallace .   2004 .   Hedgehogs  and  retinal  ganglion  cells: 
organizers of the mammalian retina.       Neuroreport   .    15 : 479  –  482 .    
   Dakubo ,   G.D. ,  Y.P.    Wang ,   C.    Mazerolle ,   K.    Campsall ,   A.P.    McMahon ,  and   V.A.  
  Wallace  .   2003  .   Retinal ganglion cell-derived sonic hedgehog signaling 
is required for optic disc and stalk neuroepithelial cell development.   
  Development   .    130 : 2967  –  2980 .    
   Dakubo ,   G.D. ,   S.T.    Beug ,   C.J.    Mazerolle ,   S.    Thurig ,  Y.    Wang ,  and  V.A.    Wallace . 
 2008 .  Control of glial precursor cell development in the mouse optic nerve 
by sonic hedgehog from retinal ganglion cells.       Brain Res.     1228 : 27  –  42 .    
   de  la  Pompa ,   J.L. ,   A.    Wakeham ,   K.M.    Correia ,   E.    Samper ,   S.    Brown ,   R.J.  
 Aguilera ,   T.    Nakano ,   T.    Honjo ,   T.W.    Mak ,   J.    Rossant ,  and   R.A.    Conlon . 
 1997 .  Conservation of the Notch signalling pathway in mammalian neuro-
genesis.     Development   .    124 : 1139  –  1148 .  
   Donovan ,   S.L. ,  and   M.A.    Dyer .   2005 .   Regulation  of  proliferation  during  central 
nervous system development.       Semin. Cell Dev. Biol.     16 : 407  –  421 .    
   Frank-Kamenetsky ,   M. ,   X.M.    Zhang ,   S.    Bottega ,   O.    Guicherit ,   H.    Wichterle ,   H.  
 Dudek ,   D.    Bumcrot ,   F.Y.    Wang ,   S.    Jones ,   J.    Shulok ,   et  al .   2002 .   Small-
molecule modulators of Hedgehog signaling: identifi  cation and charac-
terization of Smoothened agonists and antagonists.       J. Biol.     1 : 10 .    
   Fu ,   W. ,  and   N.E.    Baker .   2003 .   Deciphering  synergistic  and  redundant  roles  of 
Hedgehog, Decapentaplegic and Delta that drive the wave of differentia-
tion in Drosophila eye development.       Development   .    130 : 5229  –  5239 .    
   Furukawa ,   T. ,   S.    Mukherjee ,   Z.Z.    Bao ,   E.M.    Morrow ,  and   C.L.    Cepko .   2000 . 
  rax, Hes1, and notch1 promote the formation of Muller glia by postnatal 
retinal progenitor cells.       Neuron   .    26 : 383  –  394 .    
   Geling ,  A. ,   H.    Steiner ,   M.   Willem ,   L.    Bally-Cuif ,  and   C.    Haass .   2002 .  A  gamma-
secretase inhibitor blocks Notch signaling in vivo and causes a severe 
neurogenic phenotype in zebrafi   sh.     EMBO Rep.     3 : 688  –  694 .    
   Goodrich ,   L.V. ,   L.    Milenkovic ,   K.M.    Higgins ,  and   M.P.    Scott .   1997 .  Altered  neu-
ral cell fates and medulloblastoma in mouse patched mutants.       Science   .  
 277 : 1109  –  1113 .    
   Hashimoto ,   T. ,   X.M.    Zhang ,   B.Y.    Chen  , and   X.J.    Yang .   2006 .   VEGF  activates 
divergent intracellular signaling components to regulate retinal pro-
genitor cell proliferation and neuronal differentiation.       Development   .  
 133 : 2201  –  2210 .    
   Hays ,  R. ,  K.T.   Buchanan ,  C.   Neff , and  T.V.   Orenic .  1999 .  Patterning of  Drosophila  
leg sensory organs through combinatorial signaling by hedgehog, deca-
pentaplegic and wingless.       Development   .    126 : 2891  –  2899 .  
   Hirata ,   H. ,   S.   Yoshiura ,   T.    Ohtsuka ,  Y.    Bessho ,   T.    Harada ,   K.   Yoshikawa ,  and   R.  
  Kageyama  .   2002  .   Oscillatory expression of the bHLH factor Hes1 regu-
lated by a negative feedback loop.       Science   .    298 : 840  –  843 .    
   Hori ,   K. ,   J.    Cholewa-Waclaw ,  Y.    Nakada ,   S.M.    Glasgow ,   T.    Masui ,   R.M.    Henke , 
 H.    Wildner ,   B.    Martarelli ,   T.M.    Beres ,   J.A.    Epstein ,   et  al .   2008 .   A  non-
classical bHLH Rbpj transcription factor complex is required for speci-
fi  cation of GABAergic neurons independent of Notch signaling.       Genes 
Dev.     22 : 166  –  178 .    
   Hu ,   M.C. ,   R.    Mo ,   S.    Bhella ,   C.W.    Wilson ,   P.T.    Chuang ,   C.C.    Hui ,  and 
 N.D.    Rosenblum .   2006 .   GLI3-dependent  transcriptional  repression  of 
Gli1, Gli2 and kidney patterning genes disrupts renal morphogenesis.   
  Development   .    133 : 569  –  578 .    
   Huntzicker ,   E.G. ,   I.S.    Estay ,   H.    Zhen ,   L.A.    Lokteva ,   P.K.    Jackson ,  and  A.E.    Oro . 
  2006  .   Dual degradation signals control Gli protein stability and tumor 
formation.     Genes Dev.     20 : 276  –  281 .    
   Hutchin ,  M.E. ,  M.S.   Kariapper ,  M.   Grachtchouk ,  A.   Wang ,  L.   Wei ,  D.   Cummings , 
 J.    Liu ,   L.E.    Michael ,   A.    Glick ,  and   A.A.    Dlugosz .   2005 .   Sustained 
Hedgehog signaling is required for basal cell carcinoma proliferation 
and survival: conditional skin tumorigenesis recapitulates the hair growth 
cycle.     Genes Dev.     19 : 214  –  223 .    
   Ingram ,   W.J. ,   K.I.    McCue ,   T.H.    Tran ,   A.R.    Hallahan ,  and   B.J.    Wainwright .   2008 . 
 Sonic Hedgehog regulates Hes1 through a novel mechanism that is indepen-
dent of canonical Notch pathway signalling.       Oncogene   .    27 : 1489  –  1500 .    
   Ishibashi ,   M. ,   S.L.   Ang ,   K.    Shiota ,   S.    Nakanishi ,   R.    Kageyama ,  and   F.    Guillemot . 
  1995  .   Targeted disruption of mammalian hairy and Enhancer of split ho-
molog-1 (HES-1) leads to up-regulation of neural helix-loop-helix fac-
tors, premature neurogenesis, and severe neural tube defects.       Genes Dev.   
 9 : 3136  –  3148 .    
   Jadhav ,   A.P. ,   H.A.    Mason ,  and   C.L.    Cepko .   2006 .   Notch  1  inhibits  photore-
ceptor production in the developing mammalian retina.       Development   .  
 133 : 913  –  923 .    
   Jensen ,   A.M. ,  and   V.A.    Wallace .   1997 .   Expression  of  Sonic  hedgehog  and  its 
putative role as a precursor cell mitogen in the developing mouse retina.   
  Development   .    124 : 363  –  371 .  
   Kageyama ,   R. ,  and   T.    Ohtsuka  .   1999  .   The Notch-Hes pathway in mammalian 
neural development.       Cell Res.     9 : 179  –  188 .    JCB • VOLUME 184 • NUMBER 1 • 2009  112
   Solecki ,   D.J. ,   X.L.    Liu ,   T.    Tomoda ,   Y.    Fang ,  and   M.E.    Hatten .   2001 .   Activated 
Notch2 signaling inhibits differentiation of cerebellar granule neuron pre-
cursors by maintaining proliferation.       Neuron   .    31 : 557  –  568 .    
   Stockhausen ,   M.T. ,   J.    Sjolund ,  and   H.    Axelson .   2005 .   Regulation  of  the  Notch 
target gene Hes-1 by TGFalpha induced Ras/MAPK signaling in human 
neuroblastoma cells.       Exp. Cell Res.     310 : 218  –  228 .    
   Strom ,   A. ,   P.    Castella ,   J.    Rockwood ,   J.    Wagner ,  and   M.    Caudy .   1997 . 
  Mediation of NGF signaling by post-translational inhibition of HES-1, 
a basic helix-loop-helix repressor of neuronal differentiation.       Genes Dev.   
 11 : 3168  –  3181 .    
   Takatsuka ,   K. ,   J.    Hatakeyama ,  Y.    Bessho ,  and   R.    Kageyama .   2004  .   Roles of the 
bHLH gene Hes1 in retinal morphogenesis.       Brain Res.     1004 : 148  –  155 .    
   Tomita ,   K. ,   M.    Ishibashi ,   K.    Nakahara ,   S.L.   Ang ,   S.    Nakanishi ,   F.    Guillemot ,  and 
 R.    Kageyama .   1996  .   Mammalian hairy and Enhancer of split homolog 1 
regulates differentiation of retinal neurons and is essential for eye mor-
phogenesis.     Neuron   .    16 : 723  –  734 .    
   Villavicencio ,   E.H. ,   D.O.    Walterhouse ,  and   P.M.    Iannaccone .   2000 .   The  sonic 
hedgehog-patched-gli pathway in human development and disease.       Am. 
J. Hum. Genet.     67 : 1047  –  1054 .  
   Waid ,   D.K. ,  and   S.C.    McLoon .   1998 .   Ganglion  cells  infl  uence the fate of divid-
ing retinal cells in culture.       Development   .    125 : 1059  –  1066 .  
   Wallace ,   V.A.    1999 .   Purkinje-cell-derived  Sonic  hedgehog  regulates  granule 
neuron precursor cell proliferation in the developing mouse cerebellum.   
  Curr. Biol.     9 : 445  –  448 .    
   Wang ,   Y.P. ,   G.    Dakubo ,   P.    Howley ,   K.D.    Campsall ,   C.J.    Mazarolle ,   S.A.    Shiga , 
 P.M.    Lewis ,   A.P.    McMahon ,  and   V.A.    Wallace .   2002 .   Development  of 
normal retinal organization depends on Sonic hedgehog signaling from 
ganglion cells.       Nat. Neurosci.     5 : 831  –  832 .    
   Wang ,   Y. ,   G.D.    Dakubo ,   S.    Thurig ,   C.J.    Mazerolle ,  and   V.A.    Wallace .   2005 . 
  Retinal ganglion cell-derived sonic hedgehog locally controls prolifera-
tion and the timing of RGC development in the embryonic mouse retina.   
  Development   .    132 : 5103  –  5113 .    
   Xie ,   J. ,   M.    Murone ,   S.M.    Luoh ,   A.    Ryan ,   Q.    Gu ,   C.    Zhang ,   J.M.    Bonifas ,   C.W.  
 Lam ,   M.    Hynes ,   A.    Goddard ,   et  al .   1998 .   Activating  Smoothened  muta-
tions in sporadic basal-cell carcinoma.       Nature   .    391 : 90  –  92 .    
   Yaron ,   O. ,   C.    Farhy ,   T.    Marquardt ,   M.    Applebury ,  and   R.    Ashery-Padan .   2006 . 
  Notch1 functions to suppress cone-photoreceptor fate specifi  cation in the 
developing mouse retina.       Development   .    133 : 1367  –  1378 .    
   Young ,   R.W.    1985  .   Cell proliferation during postnatal development of the retina 
in the mouse.       Brain Res.     353 : 229  –  239 .  
   Yu ,   C. ,   C.J.    Mazerolle ,   S.    Thurig ,   Y.    Wang ,   M.    Pacal ,   R.    Bremner ,  and   V.A.  
  Wallace  .   2006  .   Direct and indirect effects of hedgehog pathway activa-
tion in the mammalian retina.       Mol. Cell. Neurosci.     32 : 274  –  282 .    
   Zhang ,   J. ,   B.    Wang ,   Z.    Xiao ,   Y.    Zhao ,   B.    Chen ,   J.    Han ,   Y.    Gao ,   W.    Ding ,   H.  
 Zhang ,  and   J.    Dai .   2008 .   Olfactory  ensheathing  cells  promote  prolifera-
tion and inhibit neuronal differentiation of neural progenitor cells through 
activation of Notch signaling.       Neuroscience   .    153 : 406  –  413 .    
   Zhang ,   S.S. ,   X.Y.    Fu ,  and   C.J.    Barnstable .   2002 .   Tissue  culture  studies  of  retinal 
development.     Methods   .    28 : 439  –  447 .    
   Zhang ,   X.M. ,  and   X.J.   Yang .   2001 .   Regulation  of  retinal  ganglion  cell  production 
by Sonic hedgehog.       Development   .    128 : 943  –  957 .          